Alyeska Investment Group
PLRX icon

Alyeska Investment Group’s Pliant Therapeutics PLRX Stock Holding History

Alyeska Investment Group’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-20,560
Closed -$466K – 579
2020
Q3 		$466K Sell
20,560
-50,000
-71% -$1.25M 0.01% 422
2020
Q2 		$2.29M Buy
+70,560
New +$1.87M 0.03% 346

Other funds holding PLRX

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Alyeska Investment Group's PLRX Position: Q4 2020 in Review

Alyeska Investment Group sold out of Pliant Therapeutics (PLRX) in Q4 2020, closing a stake of 20,560 shares — an estimated $466K sold.

Alyeska Investment Group first reported a position in PLRX in Q2 2020 and held it in 2 quarters. The position peaked at $2.29M in Q2 2020. 61 funds tracked by Wall St. Rank hold PLRX as of Q4 2020.

  • Alyeska Investment Group reported no remaining Pliant Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Alyeska Investment Group sold 20,560 Pliant Therapeutics shares in Q4 2020, an estimated $466K.
  • Alyeska Investment Group first reported a position in Pliant Therapeutics in Q2 2020 and held it in 2 quarters.
  • Alyeska Investment Group's Pliant Therapeutics position peaked at $2.29M in Q2 2020.
  • 61 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q4 2020.

Based on Alyeska Investment Group's 13F filing for Q4 2020, filed 16 Feb 2021.